Sunday, 08 December 2019

Shanghai Fosun buys 50% stake in Guangzhou Nanyang Tumour Hospital

16 October 2013 | News | By BioSpectrum Bureau

Singapore: Shanghai Fosun Pharmaceutical has purchased a 50 percent stake in Guangzhou Nanyang Tumour Hospital.

Fosun Pharma is on the spree of developing medical services and has purchased hospitals in China and abroad. It is also planning to building an international medical aircraft carrier.

According to Fosun Pharma, high-level tumour medical services and extensive international influence of Guangzhou Nanyang Tumour Hospital could be helpful for its entrance into the field of international tumour medical treatment from a higher starting point.

Guangzhou Nanyang Tumour Hospital is an international authoritative tumour specialized hospital.

 

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Podcast

 

Survey Box

Is APAC region emerging as a leader in assistive technologies?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls